Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ketoconazole and other potent antimycotic azoles exhibit pronounced activity against Trypanosoma cruzi, Plasmodium berghei and Entamoeba histolytica in vivo.

× No keyword cloud information.

6 in total

1. Ketoconazole-induced drop in serum and saliva testosterone.

Authors: T Schürmeyer; E Nieschlag
Journal: Lancet Date: 1982-11-13 Impact factor: 79.321

2. Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum.

Authors: M A Pfaller; D J Krogstad
Journal: J Infect Dis Date: 1981-10 Impact factor: 5.226

3. In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.

Authors: J D Berman
Journal: J Infect Dis Date: 1982-02 Impact factor: 5.226

4. Oral ketoconazole in the treatment of leishmaniasis.

Authors: F G Urcuyo; N Zaias
Journal: Int J Dermatol Date: 1982-09 Impact factor: 2.736

5. Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent.

Authors: J Heeres; L J Backx; J H Mostmans; J Van Cutsem
Journal: J Med Chem Date: 1979-08 Impact factor: 7.446

6. The activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.

Authors: W Raether; H Seidenath
Journal: Ann Trop Med Parasitol Date: 1983-02

6 in total

8 in total

1. Antiproliferative effects and mechanism of action of ICI 195,739, a novel bis-triazole derivative, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors: J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal: Antimicrob Agents Chemother Date: 1991-04 Impact factor: 5.191

2. Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivative with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi.

Authors: K Lazardi; J A Urbina; W de Souza
Journal: Antimicrob Agents Chemother Date: 1991-04 Impact factor: 5.191

3. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

Authors: J A Urbina; K Lazardi; T Aguirre; M M Piras; R Piras
Journal: Antimicrob Agents Chemother Date: 1988-08 Impact factor: 5.191

4. Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease.

Authors: R A Maldonado; J Molina; G Payares; J A Urbina
Journal: Antimicrob Agents Chemother Date: 1993-06 Impact factor: 5.191

5. Mevinolin (lovastatin) potentiates the antiproliferative effects of ketoconazole and terbinafine against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

Authors: J A Urbina; K Lazardi; E Marchan; G Visbal; T Aguirre; M M Piras; R Piras; R A Maldonado; G Payares; W de Souza
Journal: Antimicrob Agents Chemother Date: 1993-03 Impact factor: 5.191

Review 6. Terbinafine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial mycoses.

Authors: J A Balfour; D Faulds
Journal: Drugs Date: 1992-02 Impact factor: 9.546

Review 7. CYP51 as drug targets for fungi and protozoan parasites: past, present and future.

Authors: Galina I Lepesheva; Laura Friggeri; Michael R Waterman
Journal: Parasitology Date: 2018-04-12 Impact factor: 3.234

8. The use of 5-fluorocytosine and ketoconazole in the culture of the erythrocytic stages of Plasmodium falciparum and some tumor cell lines.

Authors: E F Roth; J C McKitrick; F Herz
Journal: Experientia Date: 1989-05-15

8 in total